Simplex Trading
URGN icon

Simplex Trading’s UroGen Pharma URGN Stock Holding History

Simplex Trading’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.7K Sell
1,105
-6,961
-86% -$189K ﹤0.01% 6497
2026
Q1 		$145K Sell
8,066
-14,043
-64% -$282K ﹤0.01% 4668
2025
Q4 		$518K Buy
+22,109
New +$480K ﹤0.01% 3274
2025
Q3 		– Sell
-185,030
Closed -$3.32M – 10135
2025
Q2 		$2.53M Buy
185,030
+184,698
+55,632% +$1.77M ﹤0.01% 1900
2025
Q1 		$3K Buy
+332
New +$3.54K ﹤0.01% 7895
2024
Q4 		– Sell
-19,031
Closed -$228K – 9690
2024
Q3 		$241K Buy
19,031
+8,412
+79% +$125K ﹤0.01% 4336
2024
Q2 		$178K Buy
10,619
+7,814
+279% +$111K ﹤0.01% 4771
2024
Q1 		$42K Sell
2,805
-3,846
-58% -$62.9K ﹤0.01% 6424
2023
Q4 		$99K Buy
6,651
+3,501
+111% +$45.4K ﹤0.01% 5403
2023
Q3 		$44K Sell
3,150
-31,189
-91% -$501K ﹤0.01% 5930
2023
Q2 		$355K Sell
34,339
-622
-2% -$6.86K ﹤0.01% 3661
2023
Q1 		$323K Buy
34,961
+31,661
+959% +$291K ﹤0.01% 3760
2022
Q4 		$29K Sell
3,300
-545
-14% -$5.16K ﹤0.01% 6520
2022
Q3 		$31K Buy
3,845
+3,725
+3,104% +$30.8K ﹤0.01% 7046
2022
Q2 		$0 Sell
120
-166
-58% -$1.14K ﹤0.01% 11157
2022
Q1 		$2K Buy
286
+87
+44% +$678 ﹤0.01% 9948
2021
Q4 		$1K Buy
199
+190
+2,111% +$2.68K ﹤0.01% 10264
2021
Q3 		$0 Hold
9
– – ﹤0.01% 9893
2021
Q2 		$0 Sell
9
-352
-98% -$6.37K ﹤0.01% 10745
2021
Q1 		$7K Buy
361
+75
+26% +$1.59K ﹤0.01% 8097
2020
Q4 		$5K Buy
+286
New +$5.99K ﹤0.01% 7739
2020
Q1 		– Sell
-12,262
Closed -$331K – 8326
2019
Q4 		$409K Buy
12,262
+5,504
+81% +$150K ﹤0.01% 2951
2019
Q3 		$161K Buy
+6,758
New +$221K ﹤0.01% 3795

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Simplex Trading's URGN Position: Q2 2026 in Review

Simplex Trading reduced its UroGen Pharma (URGN) stake by 86% in Q2 2026, selling an estimated $189K and leaving 1,105 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6497.

Simplex Trading first reported a position in URGN in Q3 2019 and has held it in 23 quarters since. The position peaked at $2.53M in Q2 2025. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Simplex Trading held 1,105 shares of UroGen Pharma worth $40.7K as of Q2 2026.
  • Simplex Trading sold 6,961 UroGen Pharma shares in Q2 2026, an estimated $189K.
  • UroGen Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6497 holding.
  • Simplex Trading first reported a position in UroGen Pharma in Q3 2019 and has held it in 23 quarters since.
  • Simplex Trading's UroGen Pharma position peaked at $2.53M in Q2 2025.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.